Selected research
Industry Research
Riboflavin 5'-phosphate Industry Research Report 2026
Market perspective
The global Riboflavin 5'-phosphate market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Riboflavin 5'-phosphate is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Riboflavin 5'-phosphate is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Riboflavin 5'-phosphate is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Riboflavin 5'-phosphate include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Riboflavin 5'-phosphate market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Riboflavin 5'-phosphate.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Riboflavin 5'-phosphate Market by Company
REVERE
Macklin
ALADDIN
Toronto Research Chemicals
SVAK Life Sciences
Selleck Chemicals
Pharmaffiliates
Merck
Medchem Express
Combi-Blocks
BLD Pharmatech
Biosynth
Ambeed
Riboflavin 5'-phosphate Segment by Type
More than 90%
Less than 90%
0.9
Riboflavin 5'-phosphate Segment by Application
Drug
Feed
Food
Riboflavin 5'-phosphate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Riboflavin 5'-phosphate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Riboflavin 5'-phosphate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Riboflavin 5'-phosphate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Riboflavin 5'-phosphate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Riboflavin 5'-phosphate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Riboflavin 5'-phosphate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- More than 90%
- Less than 90%
- 0.9
Applications
- Drug
- Feed
- Food
Companies covered
- REVERE
- Macklin
- ALADDIN
- Toronto Research Chemicals
- SVAK Life Sciences
- Selleck Chemicals
- Pharmaffiliates
- Merck
- Medchem Express
- Combi-Blocks
- BLD Pharmatech
- Biosynth
- Ambeed
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Riboflavin 5'-phosphate by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 More than 90%
- 2.2.3 Less than 90%
- 2.2.4 0.9
- 2.3 Riboflavin 5'-phosphate by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Drug
- 2.3.3 Feed
- 2.3.4 Food
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Riboflavin 5'-phosphate Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Riboflavin 5'-phosphate Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Riboflavin 5'-phosphate Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Riboflavin 5'-phosphate Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Riboflavin 5'-phosphate Production by Manufacturers (2021-2026)
- 3.2 Global Riboflavin 5'-phosphate Production Value by Manufacturers (2021-2026)
- 3.3 Global Riboflavin 5'-phosphate Average Price by Manufacturers (2021-2026)
- 3.4 Global Riboflavin 5'-phosphate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Riboflavin 5'-phosphate Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Riboflavin 5'-phosphate Manufacturers, Product Type & Application
- 3.7 Global Riboflavin 5'-phosphate Manufacturers Established Date
- 3.8 Global Riboflavin 5'-phosphate Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 REVERE
- 4.1.1 REVERE Riboflavin 5'-phosphate Company Information
- 4.1.2 REVERE Riboflavin 5'-phosphate Business Overview
- 4.1.3 REVERE Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 REVERE Product Portfolio
- 4.1.5 REVERE Recent Developments
- 4.2 Macklin
- 4.2.1 Macklin Riboflavin 5'-phosphate Company Information
- 4.2.2 Macklin Riboflavin 5'-phosphate Business Overview
- 4.2.3 Macklin Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Macklin Product Portfolio
- 4.2.5 Macklin Recent Developments
- 4.3 ALADDIN
- 4.3.1 ALADDIN Riboflavin 5'-phosphate Company Information
- 4.3.2 ALADDIN Riboflavin 5'-phosphate Business Overview
- 4.3.3 ALADDIN Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 ALADDIN Product Portfolio
- 4.3.5 ALADDIN Recent Developments
- 4.4 Toronto Research Chemicals
- 4.4.1 Toronto Research Chemicals Riboflavin 5'-phosphate Company Information
- 4.4.2 Toronto Research Chemicals Riboflavin 5'-phosphate Business Overview
- 4.4.3 Toronto Research Chemicals Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Toronto Research Chemicals Product Portfolio
- 4.4.5 Toronto Research Chemicals Recent Developments
- 4.5 SVAK Life Sciences
- 4.5.1 SVAK Life Sciences Riboflavin 5'-phosphate Company Information
- 4.5.2 SVAK Life Sciences Riboflavin 5'-phosphate Business Overview
- 4.5.3 SVAK Life Sciences Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 SVAK Life Sciences Product Portfolio
- 4.5.5 SVAK Life Sciences Recent Developments
- 4.6 Selleck Chemicals
- 4.6.1 Selleck Chemicals Riboflavin 5'-phosphate Company Information
- 4.6.2 Selleck Chemicals Riboflavin 5'-phosphate Business Overview
- 4.6.3 Selleck Chemicals Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Selleck Chemicals Product Portfolio
- 4.6.5 Selleck Chemicals Recent Developments
- 4.7 Pharmaffiliates
- 4.7.1 Pharmaffiliates Riboflavin 5'-phosphate Company Information
- 4.7.2 Pharmaffiliates Riboflavin 5'-phosphate Business Overview
- 4.7.3 Pharmaffiliates Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Pharmaffiliates Product Portfolio
- 4.7.5 Pharmaffiliates Recent Developments
- 4.8 Merck
- 4.8.1 Merck Riboflavin 5'-phosphate Company Information
- 4.8.2 Merck Riboflavin 5'-phosphate Business Overview
- 4.8.3 Merck Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Merck Product Portfolio
- 4.8.5 Merck Recent Developments
- 4.9 Medchem Express
- 4.9.1 Medchem Express Riboflavin 5'-phosphate Company Information
- 4.9.2 Medchem Express Riboflavin 5'-phosphate Business Overview
- 4.9.3 Medchem Express Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Medchem Express Product Portfolio
- 4.9.5 Medchem Express Recent Developments
- 4.10 Combi-Blocks
- 4.10.1 Combi-Blocks Riboflavin 5'-phosphate Company Information
- 4.10.2 Combi-Blocks Riboflavin 5'-phosphate Business Overview
- 4.10.3 Combi-Blocks Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Combi-Blocks Product Portfolio
- 4.10.5 Combi-Blocks Recent Developments
- 4.11 BLD Pharmatech
- 4.11.1 BLD Pharmatech Riboflavin 5'-phosphate Company Information
- 4.11.2 BLD Pharmatech Riboflavin 5'-phosphate Business Overview
- 4.11.3 BLD Pharmatech Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 BLD Pharmatech Product Portfolio
- 4.11.5 BLD Pharmatech Recent Developments
- 4.12 Biosynth
- 4.12.1 Biosynth Riboflavin 5'-phosphate Company Information
- 4.12.2 Biosynth Riboflavin 5'-phosphate Business Overview
- 4.12.3 Biosynth Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Biosynth Product Portfolio
- 4.12.5 Biosynth Recent Developments
- 4.13 Ambeed
- 4.13.1 Ambeed Riboflavin 5'-phosphate Company Information
- 4.13.2 Ambeed Riboflavin 5'-phosphate Business Overview
- 4.13.3 Ambeed Riboflavin 5'-phosphate Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Ambeed Product Portfolio
- 4.13.5 Ambeed Recent Developments
5 Global Riboflavin 5'-phosphate Production by Region
- 5.1 Global Riboflavin 5'-phosphate Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Riboflavin 5'-phosphate Production by Region: 2021-2032
- 5.2.1 Global Riboflavin 5'-phosphate Production by Region: 2021-2026
- 5.2.2 Global Riboflavin 5'-phosphate Production Forecast by Region (2027-2032)
- 5.3 Global Riboflavin 5'-phosphate Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Riboflavin 5'-phosphate Production Value by Region: 2021-2032
- 5.4.1 Global Riboflavin 5'-phosphate Production Value by Region: 2021-2026
- 5.4.2 Global Riboflavin 5'-phosphate Production Value Forecast by Region (2027-2032)
- 5.5 Global Riboflavin 5'-phosphate Market Price Analysis by Region (2021-2026)
- 5.6 Global Riboflavin 5'-phosphate Production and Value, YOY Growth
- 5.6.1 North America Riboflavin 5'-phosphate Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Riboflavin 5'-phosphate Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Riboflavin 5'-phosphate Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Riboflavin 5'-phosphate Production Value Estimates and Forecasts (2021-2032)
6 Global Riboflavin 5'-phosphate Consumption by Region
- 6.1 Global Riboflavin 5'-phosphate Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Riboflavin 5'-phosphate Consumption by Region (2021-2032)
- 6.2.1 Global Riboflavin 5'-phosphate Consumption by Region: 2021-2026
- 6.2.2 Global Riboflavin 5'-phosphate Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Riboflavin 5'-phosphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Riboflavin 5'-phosphate Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Riboflavin 5'-phosphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Riboflavin 5'-phosphate Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Riboflavin 5'-phosphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Riboflavin 5'-phosphate Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Riboflavin 5'-phosphate Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Riboflavin 5'-phosphate Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Riboflavin 5'-phosphate Production by Type (2021-2032)
- 7.1.1 Global Riboflavin 5'-phosphate Production by Type (2021-2032) & (t)
- 7.1.2 Global Riboflavin 5'-phosphate Production Market Share by Type (2021-2032)
- 7.2 Global Riboflavin 5'-phosphate Production Value by Type (2021-2032)
- 7.2.1 Global Riboflavin 5'-phosphate Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Riboflavin 5'-phosphate Production Value Market Share by Type (2021-2032)
- 7.3 Global Riboflavin 5'-phosphate Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Riboflavin 5'-phosphate Production by Application (2021-2032)
- 8.1.1 Global Riboflavin 5'-phosphate Production by Application (2021-2032) & (t)
- 8.1.2 Global Riboflavin 5'-phosphate Production Market Share by Application (2021-2032)
- 8.2 Global Riboflavin 5'-phosphate Production Value by Application (2021-2032)
- 8.2.1 Global Riboflavin 5'-phosphate Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Riboflavin 5'-phosphate Production Value Market Share by Application (2021-2032)
- 8.3 Global Riboflavin 5'-phosphate Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Riboflavin 5'-phosphate Value Chain Analysis
- 9.1.1 Riboflavin 5'-phosphate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Riboflavin 5'-phosphate Production Mode & Process
- 9.2 Riboflavin 5'-phosphate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Riboflavin 5'-phosphate Distributors
- 9.2.3 Riboflavin 5'-phosphate Customers
10 Global Riboflavin 5'-phosphate Analyzing Market Dynamics
- 10.1 Riboflavin 5'-phosphate Industry Trends
- 10.2 Riboflavin 5'-phosphate Industry Drivers
- 10.3 Riboflavin 5'-phosphate Industry Opportunities and Challenges
- 10.4 Riboflavin 5'-phosphate Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst